PATENT CLAIM ANALYSIS

Application Number: 15753291
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["564", "152000"]

Abstract:
Disclosed herein are pharmaceutical salts of a cationic protonated polyamine pharmaceutical agent and an anionic organic carboxylate which is hydrophobic when in protonated form, particularly suited for oral administration, where these salts have good bioavailability in solid dosage forms and may be used in the treatment of cancer and other medical conditions for which the pharmaceutical agent is intended.

Claim (Index 12):
The method of  claim 9  wherein the solid residue is formed by precipitation from the solution.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 1.31915
- Patent Class: 564.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['09713512', '09396523', '12294462', '11062481', '15353213']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7142558654055599
- 35 USC 102 Novelty (BERT): 0.5314317117630928
- Combined Prediction Score: 0.6959734500413132
- Mean Citation Score: 214.154076
- Max Citation Score: 219.97829
- Similarity Product: 124.29375160860656

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test